188 related articles for article (PubMed ID: 36332477)
1. Effects of gentamicin inducing readthrough premature stop Codons: A study of alpha-L-iduronidase nonsense variants in COS-7 Cells.
Ngiwsara L; Sawangareetrakul P; Wattanasirichaigoon D; Tim-Aroon T; Dejkhamron P; Champattanachai V; Ketudat-Cairns JR; Svasti J
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):147-154. PubMed ID: 36332477
[TBL] [Abstract][Full Text] [Related]
2. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
[TBL] [Abstract][Full Text] [Related]
3. Long-term nonsense suppression therapy moderates MPS I-H disease progression.
Gunn G; Dai Y; Du M; Belakhov V; Kandasamy J; Schoeb TR; Baasov T; Bedwell DM; Keeling KM
Mol Genet Metab; 2014 Mar; 111(3):374-381. PubMed ID: 24411223
[TBL] [Abstract][Full Text] [Related]
4. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
Keeling KM; Brooks DA; Hopwood JJ; Li P; Thompson JN; Bedwell DM
Hum Mol Genet; 2001 Feb; 10(3):291-9. PubMed ID: 11159948
[TBL] [Abstract][Full Text] [Related]
5. Ataluren suppresses a premature termination codon in an MPS I-H mouse.
Wang D; Xue X; Gunn G; Du M; Siddiqui A; Weetall M; Keeling KM
J Mol Med (Berl); 2022 Aug; 100(8):1223-1235. PubMed ID: 35857082
[TBL] [Abstract][Full Text] [Related]
6. Chloramphenicol enhances IDUA activity on fibroblasts from mucopolysaccharidosis I patients.
Mayer FQ; Artigalás OA; Lagranha VL; Baldo G; Schwartz IV; Matte U; Giugliani R
Curr Pharm Biotechnol; 2013; 14(2):194-8. PubMed ID: 23167761
[TBL] [Abstract][Full Text] [Related]
7. p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells.
Ngiwsara L; Ketudat-Cairns JR; Sawangareetrakul P; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Tim-Aroon T; Wattanasirichaigoon D; Svasti J
Ann Hum Genet; 2018 May; 82(3):150-157. PubMed ID: 29282708
[TBL] [Abstract][Full Text] [Related]
8. The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse.
Wang D; Belakhov V; Kandasamy J; Baasov T; Li SC; Li YT; Bedwell DM; Keeling KM
Mol Genet Metab; 2012 Jan; 105(1):116-25. PubMed ID: 22056610
[TBL] [Abstract][Full Text] [Related]
9. Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome).
Siddiqui A; Dundar H; Sharma J; Kaczmarczyk A; Echols J; Dai Y; Sun CR; Du M; Liu Z; Zhao R; Wood T; Sanders S; Rasmussen L; Bostwick JR; Augelli-Szafran C; Suto M; Rowe SM; Bedwell DM; Keeling KM
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901952
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.
Wang D; Shukla C; Liu X; Schoeb TR; Clarke LA; Bedwell DM; Keeling KM
Mol Genet Metab; 2010 Jan; 99(1):62-71. PubMed ID: 19751987
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Chromenopyridine Derivatives as Readthrough-Inducing Drugs.
Kawai S; Takashima S; Ando M; Shintaku S; Takeda S; Otake K; Ito Y; Fukui M; Yamamoto M; Shoji Y; Shirahase H; Kitao T
Chem Pharm Bull (Tokyo); 2023; 71(12):859-878. PubMed ID: 38044139
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside-Induced Premature Stop Codon Read-Through of Mucopolysaccharidosis Type I Patient Q70X and W402X Mutations in Cultured Cells.
Kamei M; Kasperski K; Fuller M; Parkinson-Lawrence EJ; Karageorgos L; Belakhov V; Baasov T; Hopwood JJ; Brooks DA
JIMD Rep; 2014; 13():139-47. PubMed ID: 24193436
[TBL] [Abstract][Full Text] [Related]
13. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
Keeling KM; Bedwell DM
J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Novel Triaryl Derivatives with Readthrough-Inducing Activity.
Kawai S; Takashima S; Ando M; Shintaku S; Takeda S; Otake K; Ito Y; Fukui M; Yamamoto M; Shoji Y; Shirahase H; Kitao T
Chem Pharm Bull (Tokyo); 2023; 71(9):701-716. PubMed ID: 37661376
[TBL] [Abstract][Full Text] [Related]
15. A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants.
Bremer S; Ohlsson A; Brodtkorb E; Rootwelt H; Rootwelt T; Woldseth B; Mørkrid L
Mol Genet Metab; 2011 Nov; 104(3):289-94. PubMed ID: 21831683
[TBL] [Abstract][Full Text] [Related]
16. Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons.
Matalonga L; Arias Á; Tort F; Ferrer-Cortés X; Garcia-Villoria J; Coll MJ; Gort L; Ribes A
Neurotherapeutics; 2015 Oct; 12(4):874-86. PubMed ID: 26169295
[TBL] [Abstract][Full Text] [Related]
17. Pseudouridine-mediated stop codon readthrough in
Adachi H; Yu YT
RNA; 2020 Sep; 26(9):1247-1256. PubMed ID: 32434780
[TBL] [Abstract][Full Text] [Related]
18. A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I.
Prommajan K; Ausavarat S; Srichomthong C; Puangsricharern V; Suphapeetiporn K; Shotelersuk V
Mol Vis; 2011 Feb; 17():456-60. PubMed ID: 21364962
[TBL] [Abstract][Full Text] [Related]
19. Evidence for degradation of mRNA encoding alpha-L-iduronidase in Hurler fibroblasts with premature termination alleles.
Menon KP; Neufeld EF
Cell Mol Biol (Noisy-le-grand); 1994 Nov; 40(7):999-1005. PubMed ID: 7849567
[TBL] [Abstract][Full Text] [Related]
20. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
